Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-06

Clinical Trial Update: A Study of Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Brief Behavioral Activation to treat depression in older adult cancer survivors. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Survivorship | Phase 2 | Status: ACTIVE_NOT_RECRUITING